Due to the complexity of clinical studies and the multiple roles of FXa in coagulation and host defense against infection, it is not surprising that there were inconsistent conclusions from two retrospective studies of COVID-19 as to whether anticoagulation increased or decreased mortality61,62. This evidence concerns the gene F10 and COVID-19.